The American Heart Association has published a pioneering study warning that synthetic cooling additives in e-cigarettes, which deliver a popular “ice” sensation, may pose severe risks to heart health. This research comes amid growing global scrutiny over unregulated vape ingredients that bypass traditional flavor bans.
While e-cigarettes are frequently marketed as safer alternatives to traditional smoking, public health experts are raising alarms over synthetic cooling agents like WS-3 and WS-23. Manufacturers use these compounds to suppress the harshness of vapor, making inhalation smoother. Because these agents produce a physical sensation rather than a flavor, they frequently escape the strict regulatory bans applied to flavored vapes, resulting in concentrations that sometimes exceed nicotine levels.
To evaluate the cardiovascular impact of these chemicals, researchers conducted a dual-phase laboratory investigation analyzing both animal models and human stem-cell-derived cardiac cells:
| Testing Model | Key Findings & Cardiovascular Impacts |
|---|---|
| Animal Models (In Vivo) | Significant increase in premature heartbeats (specifically with WS-23).Accelerated heart rate (tachycardia).Altered electrical recovery times in the heart. |
| Human Cardiac Cells (In Vitro) | No major changes under normal resting conditions.Under simulated stress (norepinephrine/adrenaline), electrical signaling was disrupted, delaying the time needed to prepare for the next heartbeat. |
The study’s findings indicate a troubling mechanism: under physiological stress—simulated using norepinephrine (noradrenaline)—cooling additives directly interfere with the electrical signaling of human heart cells. This delay in electrical resetting is a known precursor to life-threatening arrhythmias.
Broader Implications and Future Research
The researchers caution that while these laboratory and animal models provide strong warning signs, extensive clinical trials are still required to confirm these exact pathways in human users. Furthermore, the long-term cumulative effects of inhaling highly concentrated synthetic coolants remain entirely unknown.
Cardiologists are particularly concerned about the impact of “ice” vapes on vulnerable demographics. Individuals with pre-existing heart conditions, hypertension, diabetes, obesity, or pregnant women may face a significantly elevated risk of adverse cardiovascular events. The study concludes with a strong call for policymakers to close the regulatory loopholes surrounding non-flavored cooling additives.